News

What's New in the Department of Surgery

Novilase Trial Enrolling Now

Laser therapy to treat early stage breast cancer. Columbia University Medical Center is now enrolling patients in a new clinical trial examining the effectiveness of laser therapy to treat early-stage breast cancer. This new research is testing a non-surgical treatment called Novilase® Interstitial Laser Therapy (ILT). The study will test the ability of the laser to ablate (destroy) breast cancers that are equal to or less than 2 centimeters in size. Approximately 50% of breast cancer patients are estimated to qualify for inclusion in the study. Traditionally, early-stage breast cancers have been removed by surgery, i.e., lumpectomy, which can unfavorably affect the look and feel of the breast. Destroying the tumor with a laser may have advantages including: Minimal scarring, Less chance of infection, Much shorter recovery time, Preservation of natural shape (i.e., cosmetic appearance) and feel of the breast
Read More >
In the following interview, Dr. Gress explains the uses of therapeutic endoscopy in treating patients with pancreatic disease and he shares information about a very important technological advance at the Pancreas Center.
Read More >
Deborah Gerszberg, RD, CNSC, CDN, Clinical Nutritionist at The Pancreas Center, discusses how to avoid nutritional deficiencies after undergoing a Whipple Procedure for pancreatic cancer.
Read More >
Researchers at Columbia University Medical Center have discovered that certain women undergoing radiation therapy for early-stage breast cancer may have an elevated risk of developing cardiovascular disease.
Read More >
Dr. Paul Oberstein at Pancreatic Cancer Awareness Day on November 9, 2013
In the following interview, Dr. Paul Oberstein, medical oncologist at the Pancreas Center, discusses the latest advances in chemotherapy for pancreatic cancer and why he is optimistic.
Read More >

Pages